CCL vs LAB · P/E 15, rev $25.02B vs rev $174.4M
Carnival Corporation (CCL) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Carnival Corporation (CCL) is a travel services company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported CCL revenue for 2024-11-30 was $25.02B. Net income was $1.92B. Revenue was up 15.9% from 2023-11-30 to 2024-11-30. CCL currently screens at market cap $39.74B and trailing P/E 15.3.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
CCL currently screens at market cap $39.74B and trailing P/E 15.3. LAB currently screens at market cap $317.1M.
Not investment advice. Open the CCL and LAB stock pages for the full models.
Not investment advice.